Literature DB >> 10864685

Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice.

J A Lekstrom-Himes1, R A LeBlanc, L Pesnicak, M Godleski, S E Straus.   

Abstract

Murine models of gamma interferon (IFN-gamma) deficiency demonstrate the role of this cytokine in attenuating acute herpes simplex virus (HSV) disease; however, the effect of IFN-gamma on the establishment and maintenance of neuronal latency and viral reactivation is not known. Using the IFN-gamma knockout (GKO) model of IFN-gamma deficiency and sensitive quantitative PCR methods, we show that IFN-gamma significantly reduces the ganglion content of latent HSV-1 in BALB/c mice, which in turn delays viral time to reactivation following UV irradiation. Similar effects were not seen in the C57BL/6 strain. These results indicate that IFN-gamma significantly attenuates latent HSV infection in the mouse model of ocular infection but has no impact on the maintenance of latency or virus reactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864685      PMCID: PMC112181          DOI: 10.1128/jvi.74.14.6680-6683.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

2.  The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.

Authors:  R A LeBlanc; L Pesnicak; M Godleski; S E Straus
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

3.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

4.  Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.

Authors:  K A Laycock; S F Lee; R H Brady; J S Pepose
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

5.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 8.  Herpes simplex virus infection in the immunocompromised cancer patient.

Authors:  C I Bustamante; J C Wade
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

9.  Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.

Authors:  S K Burchett; L Corey; K M Mohan; J Westall; R Ashley; C B Wilson
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

10.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more
  22 in total

Review 1.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.

Authors:  Anthony J St Leger; Robert L Hendricks
Journal:  J Neurovirol       Date:  2011-12-08       Impact factor: 2.643

2.  Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.

Authors:  Sabine Vollstedt; Susi Arnold; Cornelia Schwerdel; Marco Franchini; Gottfried Alber; James P Di Santo; Mathias Ackermann; Mark Suter
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

4.  Interferon-gamma, macrophages, and virus spread after HSV-1 injection.

Authors:  Heather M Cathcart; Mei Zheng; Jason J Covar; Yi Liu; Robert Podolsky; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-07       Impact factor: 4.799

5.  Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.

Authors:  Bruno Sainz; William P Halford
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.

Authors:  Eugene M A van Rooij; Harrie L Glansbeek; Luuk A T Hilgers; Eddie G te Lintelo; Yolanda E de Visser; Wim J A Boersma; Bart L Haagmans; Andre T J Bianchi
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

9.  Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.

Authors:  J Peltoniemi; E K Broberg; A Halenius; N Setala; J-P Eralinna; A A Salmi; M Roytta; V Hukkanen
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.